2
19
↑2
↓19
—0
Evidence suggests Resistance Training maydecreaseSarcopenia.
23 studies (21 claims)
Strong consensus
Typical effective dose 50000 (50000–50000) mgacross 1 dosed study
Study Claims
| Intervention | Direction | Endpoint | Type | Population | Dosage | Title |
|---|---|---|---|---|---|---|
| modified plant-based Mediterranean diet ("vegeterranean" diet), circuit resistance training (CRT) and empagliflozin | No effect - will provide evidence of the effectiveness | delaying the progression from diabetes to sarcopenia and/or frailty | Human | — | Not specified for dairy (diet involved limited consumption). | The effect of circuit resistance training, empagliflozin or "vegeterranean diet" on physical and metabolic function in older subjects with type 2 diabetes: a study protocol for a randomized control trial (CEV-65 trial).cited 15× |
| circuit resistance training (CRT) | No effect - efficacy will be determined by assessment | sarcopenia | Human | men and women ≥65 years of age with type 2 diabetes, and low levels of physical activity | Not specified for dairy (diet involved limited consumption). | The effect of circuit resistance training, empagliflozin or "vegeterranean diet" on physical and metabolic function in older subjects with type 2 diabetes: a study protocol for a randomized control trial (CEV-65 trial).cited 15× |
| Resistance training added to aerobic exercise or high-intensity interval training | Decreases - may help to prevent or reverse | sarcopenia | Human | — | Not specified | Sarcopenia: monitoring, molecular mechanisms, and physical intervention.cited 51× |
| high-intensity resistance training (HI-RT) | Decreases - significant effect | Sarcopenia Z-score | Human | osteosarcopenic (OS) older men | Up to 1.5 g/kg/day in the HI-RT group and 1.2 g/kg/day in the control group. | The Favorable Effects of a High-Intensity Resistance Training on Sarcopenia in Older Community-Dwelling Men with Osteosarcopenia: The Randomized Controlled FrOST Study.cited 57× |
| high-intensity resistance training (HI-RT) | Decreases - significant intergroup change | Sarcopenia Z-score | Human | osteosarcopenic (OS) older men | Up to 1.5 g/kg/day in the HI-RT group and 1.2 g/kg/day in the control group. | The Favorable Effects of a High-Intensity Resistance Training on Sarcopenia in Older Community-Dwelling Men with Osteosarcopenia: The Randomized Controlled FrOST Study.cited 57× |
| high-intensity progressive resistance training (PRT) | Decreases - may support reduced risks of | sarcopenia | Human | sarcopenic older adults | Daily weekday milk-based whey-protein supplementation (exact amount not specified). | "We want more": perspectives of sarcopenic older women on the feasibility of high-intensity progressive resistance exercises and a whey-protein nutrition intervention.cited 2× |
| low-volume, remotely supervised resistance training protocol | Decreases - significant reductions | sarcopenia prevalence | Human | frail older adults attending daycare centers | 10-minute sessions, three times weekly. | Low-volume resistance training: a feasible, cost-effective strategy for musculoskeletal frailty in older adults attending daycare centers. |
| whey protein supplementation after resistance training | Increases - may be useful | treatment of sarcopenia | Human | older adults | 2,300 mg of leucine (as part of 11.0 g whey protein) twice weekly. | De-Training Effects Following Leucine-Enriched Whey Protein Supplementation and Resistance Training in Older Adults with Sarcopenia: A Randomized Controlled Trial with 24 Weeks of Follow-Up.cited 10× |
| combined intervention of leucine-enriched whey protein supplementation and resistance training | Increases - showed long-term maintenance | treating sarcopenia | Human | older adults with sarcopenia | 2,300 mg of leucine (as part of 11.0 g whey protein) twice weekly. | De-Training Effects Following Leucine-Enriched Whey Protein Supplementation and Resistance Training in Older Adults with Sarcopenia: A Randomized Controlled Trial with 24 Weeks of Follow-Up.cited 10× |
| progressive resistance training | Decreases - most well-established intervention | sarcopenia | Human | — | Not specified | Sarcopenia.cited 9× |
| Progressive resistance training | Decreases - recommended for the prevention and treatment | sarcopenia | Human | — | Not specified | The role of omega-3 in the prevention and treatment of sarcopenia.cited 126× |
| combination of resistance training with supplements containing amino acids | Decreases - is the gold standard for preventing | sarcopenia | Human | — | Not specified | Current Nutritional and Pharmacological Approaches for Attenuating Sarcopenia.cited 13× |
| Resistance training combined with amino acid-containing supplements | Decreases - is the gold standard to prevent | sarcopenia | Human | — | Not specified | Recent advances in pharmacological, hormonal, and nutritional intervention for sarcopenia.cited 22× |
| resistance training | No effect - strongly emphasize the role | chronic diseases and secondary sarcopenia | Human | individuals with chronic diseases | Not specified | Non-Pharmacological Strategies for Managing Sarcopenia in Chronic Diseases.cited 5× |
| Resistance training (RT) | Decreases - is well established to be an effective intervention to counter | indices of sarcopenia | Human | — | Not specified in the abstract. | Efficacy of Creatine Supplementation Combined with Resistance Training on Muscle Strength and Muscle Mass in Older Females: A Systematic Review and Meta-Analysis.cited 19× |
| resistance training | Decreases - effective in preventing and reversing | sarcopenia | Human | older people | Not specified | Leucine and ACE inhibitors as therapies for sarcopenia (LACE trial): study protocol for a randomised controlled trial.cited 31× |
| resistance training | Decreases - are the primary methods for treating | sarcopenia | Human | — | Not mentioned | A review of sarcopenia: Enhancing awareness of an increasingly prevalent disease.cited 201× |
| resistance training | Decreases - being one of the best treatments | sarcopenia | Human | elderly population | Not specified | Effects of different intervention combined with resistance training on musculoskeletal health in older male adults with sarcopenia: A systematic review.cited 4× |
| Resistance training (RT) | Decreases - ameliorating | sarcopenia | Human | — | Not specified | The skeletal muscle proteomic determinants of neuromuscular function in young and older women following 8 weeks of resistance training.cited 3× |
| Resistance training | Decreases - to avoid | sarcopenia | Human | people with cancer | Not specified (used as placebo in the same daily dosing protocol as creatine, 5 g/d) | Creatine Supplementation and Resistance Training in Patients With Breast Cancer (CaRTiC Study): Protocol for a Randomized Controlled Trial.cited 3× |
| Resistance training | No effect - remain the cornerstone of sarcopenia management | sarcopenia management | Human | — | Not specified | Emerging Targets and Treatments for Sarcopenia: A Narrative Review.cited 5× |
| resistance training | Decreases - significantly improved | sarcopenia prevalence | Human | prostate cancer patients on ADT | Resistance training 3 days per week; protein supplementation (50 g/day) for TRAINPRO and PRO groups. | Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial.cited 76× |
| resistance training | Decreases - are important strategies to mitigate | the sarcopenia process | Human | older individuals | Not specified | Protein Supplementation for Strength and Functionality in Older Adults: Is There Still Any Doubt? A Brief Update Review.cited 1× |
| resistance training with/without nutritional supplements (e.g., protein, vitamin D) | No effect - were mainly focused on | sarcopenia | Human | — | Not specified | Sarcopenia and sarcopenic obesity among older adults in the nordic countries: a scoping review.cited 3× |
| aerobic and resistance training exercises | Decreases - have been recognized as an effective strategy to prevent and treat | sarcopenia | Human | — | Not specified | Sarcopenia as a comorbidity of cardiovascular disease.cited 64× |